Press Releases & Statements

Investor Relations

Month Year

Month Year

AGC Biologics Expands Partnership with Novavax
- Partners
Aug 10, 2020
Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan
- Partners
Aug 7, 2020
Novavax to Host Conference Call to Discuss Second Quarter Financial and Operating Results on August 10, 2020
- Corporate and Finance
Aug 6, 2020
Novavax and Serum Institute of India Announce Development and Commercial Collaboration
- Partners
Aug 6, 2020
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
- COVID-19
Aug 4, 2020
Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate
- COVID-19
Jul 23, 2020
Novavax to Present COVID-19 Vaccine Candidate Progress at 2nd ISV COVID-19 Vaccines Virtual Congress
- COVID-19
Jul 20, 2020
Novavax Announces $1.6 Billion Funding from Operation Warp Speed
- Corporate and Finance
Jul 7, 2020
Novavax Announces Updates to Leadership Team
- Corporate and Finance
Jul 2, 2020
Novavax Expands Executive Leadership and Announces Key Promotions
- Corporate and Finance
Jun 29, 2020
Novavax to Participate in H.C. Wainwright Fireside Chat Series
- Corporate and Finance
Jun 24, 2020
Novavax Announces Additions to Executive Leadership
- Corporate and Finance
Jun 17, 2020
Novavax Appoints Biotechnology Veteran David Mott to Board of Directors
- Corporate and Finance
Jun 16, 2020
Novavax to Raise $200 Million from Private Placement with RA Capital
- Corporate and Finance
Jun 15, 2020
Novavax President of R&D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital
- COVID-19
Jun 8, 2020
Novavax Awarded Department of Defense Contract for COVID-19 Vaccine
- COVID-19
Jun 4, 2020
Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine
- Matrix-M™ Adjuvant
Jun 3, 2020
Novavax Expands Large-Scale Global Manufacturing Capacity
- Corporate and Finance
May 27, 2020
Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
- COVID-19
May 25, 2020
Novavax to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series
- COVID-19
May 11, 2020
Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
- COVID-19
May 11, 2020
Novavax Reports First Quarter 2020 Financial Results
- Corporate and Finance
May 11, 2020
Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 11, 2020
- Corporate and Finance
May 6, 2020
Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May
- COVID-19
Apr 8, 2020
Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
- Seasonal Influenza
Mar 24, 2020

Show per page